OAM
ANIP icon

Oxford Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Oxford Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,539
Closed -$595K – 480
2025
Q4 		$595K Buy
+7,539
New +$653K 0.21% 162
2019
Q4 		– Sell
-23,285
Closed -$1.7M – 1735
2019
Q3 		$1.7M Sell
23,285
-31,507
-58% -$2.36M 0.04% 640
2019
Q2 		$4.5M Buy
54,792
+44,571
+436% +$3.17M 0.1% 273
2019
Q1 		$721K Buy
10,221
+703
+7% +$41.4K 0.02% 1078
2018
Q4 		$429K Buy
9,518
+3,068
+48% +$161K 0.01% 1253
2018
Q3 		$361K Sell
6,450
-31,783
-83% -$1.94M 0.01% 1436
2018
Q2 		$2.57M Sell
38,233
-13,803
-27% -$862K 0.05% 511
2018
Q1 		$3.03M Buy
52,036
+3,708
+8% +$235K 0.06% 359
2017
Q4 		$3.18M Buy
+48,328
New +$3.01M 0.07% 355
2016
Q4 		– Sell
-21,986
Closed -$1.46M – 762
2016
Q3 		$1.46M Sell
21,986
-57,903
-72% -$3.62M 0.05% 453
2016
Q2 		$4.46M Buy
79,889
+13,810
+21% +$671K 0.15% 168
2016
Q1 		$2.22M Sell
66,079
-93,228
-59% -$3.16M 0.06% 352
2015
Q4 		$7.18M Buy
+159,307
New +$6.86M 0.17% 123

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Oxford Asset Management's ANIP Position: Q1 2026 in Review

Oxford Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q1 2026, closing a stake of 7,539 shares — an estimated $595K sold.

Oxford Asset Management first reported a position in ANIP in Q4 2015 and held it in 13 quarters. The position peaked at $7.18M in Q4 2015. 281 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Oxford Asset Management reported no remaining ANI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Oxford Asset Management sold 7,539 ANI Pharmaceuticals shares in Q1 2026, an estimated $595K.
  • Oxford Asset Management first reported a position in ANI Pharmaceuticals in Q4 2015 and held it in 13 quarters.
  • Oxford Asset Management's ANI Pharmaceuticals position peaked at $7.18M in Q4 2015.
  • 281 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Oxford Asset Management's 13F filing for Q1 2026, filed 15 May 2026.